National Cancer Institute U.S. National Institute of Health www.cancer.gov
Skip Navigation
National Cancer institute
Cancer Diagnosis Program (CDP) Division of Cancer Treatment and Diagnosis (DCTD)
Office of Biorepositories and Biospecimen Research
Launch NCI Best Practices for BiospecimenLaunch caHUB

Sign Up For Updates     
Biospecimen Research Network
Financial Sustainability Survey
Contact BBRB
Patient Corner
Skip Left Links

BRN

BRN Research Program: "Biospecimen Research for Molecular Medicine"

The BRN extramural research program is designed to (1) systematically define the impact of key pre-analytical variables in human biospecimens of specific type on downstream molecular data generated from specific molecular analysis platforms and (2) to develop innovative approaches to the control, monitoring and assessment of biospecimen quality. This research program funds directed research and development in biospecimen science that broadly supports the mission of the NCI.

The first RFP under this program, "R&D on Human Biospecimen Integrity," was released on October 1, 2008. Proposals were requested to develop innovative approaches to the control, monitoring and assessment of biospecimen quality. Four research contracts were awarded. learn more

A second RFP, "Biospecimen Contributing Institutions for Research Studies in Cancer Tissue Pre-Analytical Variables," described above, was issued on May 5, 2009 and is the first component of a larger multi-center research project designed to systematically assess the effects of human biospecimen pre-analytical variables on the outcome of genomic and proteomic studies. Data resulting from the research program will provide the basis for evidence-based biospecimen protocols that will increase the quality of human biospecimens for research and the emerging field of personalized medicine.

More information on additional funding opportunities related to this important new research initiative will be posted as they become available.


Skip Footer Links